Adverse event and Erythema multiforme

Summary:

Erythema multiforme is found among people with Adverse event, especially for people who are male, 60+ old.

The study analyzes which people have Erythema multiforme with Adverse event. It is created by eHealthMe based on reports of 19 people who have Adverse event from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Adverse event?

Adverse event is found to be associated with 1,687 drugs and 1,664 conditions by eHealthMe. Check the latest studies of Adverse event.

What is Erythema multiforme?

Erythema multiforme (a type of hypersensitivity reaction) is found to be associated with 1,707 drugs and 2,920 conditions by eHealthMe. Check the latest studies of Erythema multiforme.



On Jul, 11, 2026

19 people who have Adverse Event and Erythema Multiforme are studied.

Would you have Erythema multiforme when you have Adverse event?

Gender of people who have Adverse Event and experienced Erythema Multiforme *:

  • female: 47.37 %
  • male: 52.63 %

Age of people who have Adverse Event and experienced Erythema Multiforme *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 10.53 %
  • 50-59: 15.79 %
  • 60+: 73.68 %

Common co-existing conditions for these people *:

  1. Arrhythmias (irregular heartbeat): 4 people, 21.05%
  2. Pulmonary Embolism (blockage of the main artery of the lung): 3 people, 15.79%
  3. Insomnia (sleeplessness): 3 people, 15.79%
  4. Depression: 3 people, 15.79%
  5. Follicle Centre Lymphoma, Follicular Grade I, Ii, Iii: 3 people, 15.79%
  6. Adult T-Cell Lymphoma/leukaemia (cancer of the immune system's own t-cells): 2 people, 10.53%
  7. Anaemia (lack of blood): 2 people, 10.53%
  8. Diabetes: 2 people, 10.53%
  9. Gastroenteritis (inflammation of stomach and intestine): 1 person, 5.26%
  10. Bacterial Infection: 1 person, 5.26%

Common drugs taken by these people *:

  1. Rebetol: 8 people, 42.11%
  2. Pegintron: 7 people, 36.84%
  3. Ribavirin: 4 people, 21.05%
  4. Revlimid: 3 people, 15.79%
  5. Cotrim: 3 people, 15.79%
  6. Allegra: 3 people, 15.79%
  7. Novolin R: 3 people, 15.79%
  8. Zofran: 3 people, 15.79%
  9. Mircera: 3 people, 15.79%
  10. Clexane: 2 people, 10.53%

Common symptoms for these people *:

  1. Fever: 5 people, 26.32%
  2. Rashes (redness): 4 people, 21.05%
  3. Lymphopenia (an abnormally low level of lymphocytes in the blood): 3 people, 15.79%
  4. Anaemia (lack of blood): 3 people, 15.79%
  5. Eosinophil Count Increased: 3 people, 15.79%
  6. Pneumonia: 3 people, 15.79%
  7. Hyperglycemia (high blood sugar): 3 people, 15.79%
  8. Adult T-Cell Lymphoma/leukaemia (cancer of the immune system's own t-cells): 2 people, 10.53%
  9. Azotaemia (excess of urea or other nitrogenous compounds in the blood): 2 people, 10.53%
  10. Cerebral Haemorrhage (bleeding within the brain): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Erythema multiforme?

- Check whether Erythema multiforme is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Erythema multiforme:

All the conditions that are associated with Erythema multiforme:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Erythema multiforme and Adverse event, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: